# V F Corp: financial statements, quarterly

VFC · NYSE · CIK 103379 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 28

Pages: [Overview](/companies/vfc.md) · [Financials](/companies/vfc/financials.md) · [Filings](/companies/vfc/filings.md) · [Insiders](/companies/vfc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vfc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-07-01) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,086](/filings/0000103379-24-000018.md) | [2,920](/filings/0000103379-24-000030.md) | [2,780](/filings/0000103379-25-000007.md) | [2,247 d](/filings/0000103379-26-000030.md) | [1,769](/filings/0000103379-25-000036.md) | [2,758](/filings/0000103379-25-000060.md) | [2,834](/filings/0000103379-26-000011.md) | [2,144 d](/filings/0000103379-26-000030.md) | [1,761](/filings/0000103379-25-000036.md) | [2,803](/filings/0000103379-25-000060.md) | [2,876](/filings/0000103379-26-000011.md) | [2,166 d](/filings/0000103379-26-000030.md) |
| Cost of revenue | $m | [985](/filings/0000103379-24-000018.md) | [1,430](/filings/0000103379-24-000030.md) | [1,261](/filings/0000103379-25-000007.md) | [1,172 d](/filings/0000103379-26-000030.md) | [863](/filings/0000103379-25-000036.md) | [1,317](/filings/0000103379-25-000060.md) | [1,239](/filings/0000103379-26-000011.md) | [1,001 d](/filings/0000103379-26-000030.md) | [812](/filings/0000103379-25-000036.md) | [1,340](/filings/0000103379-25-000060.md) | [1,247](/filings/0000103379-26-000011.md) | [944 d](/filings/0000103379-26-000030.md) |
| Selling, general and administrative | $m | [1,110](/filings/0000103379-24-000018.md) | [1,139](/filings/0000103379-24-000030.md) | [1,353](/filings/0000103379-25-000007.md) | [1,198 d](/filings/0000103379-26-000030.md) | [1,029](/filings/0000103379-25-000036.md) | [1,167](/filings/0000103379-25-000060.md) | [1,318](/filings/0000103379-26-000011.md) | [1,177 d](/filings/0000103379-26-000030.md) | [1,036](/filings/0000103379-25-000036.md) | [1,150](/filings/0000103379-25-000060.md) | [1,309](/filings/0000103379-26-000011.md) | [1,160 d](/filings/0000103379-26-000030.md) |
| Operating income | $m | [(9.0)](/filings/0000103379-24-000018.md) | [351](/filings/0000103379-24-000030.md) | [(91.2)](/filings/0000103379-25-000007.md) | [(373) d](/filings/0000103379-26-000030.md) | [(123)](/filings/0000103379-25-000036.md) | [274](/filings/0000103379-25-000060.md) | [226](/filings/0000103379-26-000011.md) | [(72.9) d](/filings/0000103379-26-000030.md) | [(86.6)](/filings/0000103379-25-000036.md) | [313](/filings/0000103379-25-000060.md) | [289](/filings/0000103379-26-000011.md) | [61.5 d](/filings/0000103379-26-000030.md) |
| Interest expense | $m | [55.2](/filings/0000103379-23-000015.md) | [60.5](/filings/0000103379-23-000018.md) | [67.5](/filings/0000103379-24-000003.md) | [61.8 d](/filings/0000103379-24-000008.md) | [44.3](/filings/0000103379-25-000036.md) | [46.4](/filings/0000103379-25-000060.md) | [43.3](/filings/0000103379-26-000011.md) | [40.1 d](/filings/0000103379-26-000030.md) | [43.6](/filings/0000103379-25-000036.md) | [49.6](/filings/0000103379-25-000060.md) | [39.7](/filings/0000103379-26-000011.md) | [33.8 d](/filings/0000103379-26-000030.md) |
| Income tax | $m | [(4.9)](/filings/0000103379-24-000018.md) | [759](/filings/0000103379-24-000030.md) | [(19.6)](/filings/0000103379-25-000007.md) | [0.4 d](/filings/0000103379-26-000030.md) | [(13.4)](/filings/0000103379-25-000036.md) | [28.0](/filings/0000103379-25-000060.md) | [27.6](/filings/0000103379-26-000011.md) | [33.7 d](/filings/0000103379-26-000030.md) | [(10.2)](/filings/0000103379-25-000036.md) | [78.5](/filings/0000103379-25-000060.md) | [62.0](/filings/0000103379-26-000011.md) | [(44.0) d](/filings/0000103379-26-000030.md) |
| Net income | $m | [(57.4)](/filings/0000103379-24-000018.md) | [(451)](/filings/0000103379-24-000030.md) | [(42.5)](/filings/0000103379-25-000007.md) | [(418) d](/filings/0000103379-26-000030.md) | [(259)](/filings/0000103379-25-000036.md) | [52.2](/filings/0000103379-25-000060.md) | [168](/filings/0000103379-26-000011.md) | [(151) d](/filings/0000103379-26-000030.md) | [(116)](/filings/0000103379-25-000036.md) | [190](/filings/0000103379-25-000060.md) | [301](/filings/0000103379-26-000011.md) | [(119) d](/filings/0000103379-26-000030.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0000103379-24-000018.md) | [(1.16)](/filings/0000103379-24-000030.md) | [(0.11)](/filings/0000103379-25-000007.md) | not reported | [(0.67)](/filings/0000103379-25-000036.md) | [0.13](/filings/0000103379-25-000060.md) | [0.43](/filings/0000103379-26-000011.md) | not reported | [(0.30)](/filings/0000103379-25-000036.md) | [0.48](/filings/0000103379-25-000060.md) | [0.76](/filings/0000103379-26-000011.md) | not reported |
| Basic EPS | $ per share | [(0.15)](/filings/0000103379-24-000018.md) | [(1.16)](/filings/0000103379-24-000030.md) | [(0.11)](/filings/0000103379-25-000007.md) | not reported | [(0.67)](/filings/0000103379-25-000036.md) | [0.13](/filings/0000103379-25-000060.md) | [0.43](/filings/0000103379-26-000011.md) | not reported | [(0.30)](/filings/0000103379-25-000036.md) | [0.49](/filings/0000103379-25-000060.md) | [0.77](/filings/0000103379-26-000011.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-07-01) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | FY2026 (2026-03-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0000103379-24-000018.md) | [0.5](/filings/0000103379-24-000030.md) | [1.0](/filings/0000103379-25-000007.md) | [0.7](/filings/0000103379-26-000030.md) | [0.6](/filings/0000103379-25-000036.md) | [0.5](/filings/0000103379-25-000060.md) | [1.4](/filings/0000103379-26-000011.md) | [0.4](/filings/0000103379-26-000030.md) | [0.6](/filings/0000103379-25-000036.md) | [0.4](/filings/0000103379-25-000060.md) | [1.5](/filings/0000103379-26-000011.md) | [0.8](/filings/0000103379-26-000030.md) |
| Current assets | $bn | [5.2](/filings/0000103379-24-000018.md) | [5.2](/filings/0000103379-24-000030.md) | [4.9](/filings/0000103379-25-000007.md) | [4.2](/filings/0000103379-25-000023.md) | [4.3](/filings/0000103379-25-000036.md) | [6.5](/filings/0000103379-25-000060.md) | [5.0](/filings/0000103379-26-000011.md) | [3.8](/filings/0000103379-26-000030.md) | [4.4](/filings/0000103379-25-000036.md) | [5.1](/filings/0000103379-25-000060.md) | [5.0](/filings/0000103379-26-000011.md) | [4.0](/filings/0000103379-26-000030.md) |
| Total assets | $bn | [14.0](/filings/0000103379-24-000018.md) | [13.1](/filings/0000103379-24-000030.md) | [12.6](/filings/0000103379-25-000007.md) | [11.6](/filings/0000103379-26-000030.md) | [11.5](/filings/0000103379-25-000036.md) | [12.2](/filings/0000103379-25-000060.md) | [10.6](/filings/0000103379-26-000011.md) | [9.4](/filings/0000103379-26-000030.md) | [10.2](/filings/0000103379-25-000036.md) | [10.6](/filings/0000103379-25-000060.md) | [10.4](/filings/0000103379-26-000011.md) | [9.3](/filings/0000103379-26-000030.md) |
| Current liabilities | $bn | [3.8](/filings/0000103379-24-000018.md) | [3.5](/filings/0000103379-24-000030.md) | [4.0](/filings/0000103379-25-000007.md) | [3.5](/filings/0000103379-25-000023.md) | [4.4](/filings/0000103379-25-000036.md) | [5.0](/filings/0000103379-25-000060.md) | [3.2](/filings/0000103379-26-000011.md) | [2.7](/filings/0000103379-26-000030.md) | [3.4](/filings/0000103379-25-000036.md) | [3.8](/filings/0000103379-25-000060.md) | [3.2](/filings/0000103379-26-000011.md) | [2.2](/filings/0000103379-26-000030.md) |
| Total liabilities | $bn | [11.3](/filings/0000103379-24-000018.md) | [10.9](/filings/0000103379-24-000030.md) | [10.5](/filings/0000103379-25-000007.md) | [10.0](/filings/0000103379-25-000023.md) | [10.2](/filings/0000103379-25-000036.md) | [10.8](/filings/0000103379-25-000060.md) | [8.9](/filings/0000103379-26-000011.md) | [7.9](/filings/0000103379-26-000030.md) | [8.9](/filings/0000103379-25-000036.md) | [9.2](/filings/0000103379-25-000060.md) | [8.6](/filings/0000103379-26-000011.md) | [7.4](/filings/0000103379-26-000030.md) |
| Long-term debt | $bn | not reported | not reported | not reported | [4.7](/filings/0000103379-24-000008.md) | not reported | not reported | not reported | [3.4](/filings/0000103379-25-000023.md) | not reported | not reported | not reported | [3.5](/filings/0000103379-26-000030.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | [1.0](/filings/0000103379-24-000008.md) | not reported | not reported | not reported | [0.5](/filings/0000103379-25-000023.md) | not reported | not reported | not reported | [0.0](/filings/0000103379-26-000030.md) |
| Short-term borrowings | $bn | [0.1](/filings/0000103379-24-000018.md) | [1.0](/filings/0000103379-24-000030.md) | [0.5](/filings/0000103379-25-000007.md) | [0.3](/filings/0000103379-25-000023.md) | [0.3](/filings/0000103379-25-000036.md) | [0.5](/filings/0000103379-25-000060.md) | [0.0](/filings/0000103379-26-000011.md) | [0.0](/filings/0000103379-26-000030.md) | [0.4](/filings/0000103379-25-000036.md) | [0.5](/filings/0000103379-25-000060.md) | [0.0](/filings/0000103379-26-000011.md) | [0.0](/filings/0000103379-26-000030.md) |
| Shareholders' equity | $bn | [2.7](/filings/0000103379-24-000030.md) | [2.2](/filings/0000103379-25-000007.md) | [2.1](/filings/0000103379-25-000007.md) | [1.7](/filings/0000103379-26-000030.md) | [1.4](/filings/0000103379-25-000060.md) | [1.4](/filings/0000103379-26-000011.md) | [1.7](/filings/0000103379-26-000011.md) | [1.5](/filings/0000103379-26-000030.md) | [1.3](/filings/0000103379-25-000060.md) | [1.5](/filings/0000103379-26-000011.md) | [1.8](/filings/0000103379-26-000011.md) | [1.8](/filings/0000103379-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-07-01) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [164](/filings/0000103379-24-000018.md) | [(183) d](/filings/0000103379-24-000030.md) | [1,125 d](/filings/0000103379-25-000007.md) | [(91.2) d](/filings/0000103379-26-000030.md) | [19.8](/filings/0000103379-25-000036.md) | [(302) d](/filings/0000103379-25-000060.md) | [918 d](/filings/0000103379-26-000011.md) | [(171) d](/filings/0000103379-26-000030.md) | [(145)](/filings/0000103379-25-000036.md) | [(227) d](/filings/0000103379-25-000060.md) | [1,010 d](/filings/0000103379-26-000011.md) | [33.3 d](/filings/0000103379-26-000030.md) |
| Dividends paid | $m | [117](/filings/0000103379-24-000018.md) | [117 d](/filings/0000103379-24-000030.md) | [35.0 d](/filings/0000103379-25-000007.md) | [35.0 d](/filings/0000103379-26-000030.md) | [35.0](/filings/0000103379-25-000036.md) | [35.0 d](/filings/0000103379-25-000060.md) | [35.0 d](/filings/0000103379-26-000011.md) | [35.1 d](/filings/0000103379-26-000030.md) | [35.2](/filings/0000103379-25-000036.md) | [35.2 d](/filings/0000103379-25-000060.md) | [35.2 d](/filings/0000103379-26-000011.md) | [35.2 d](/filings/0000103379-26-000030.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-07-02) | Q2 FY2023 (2022-10-01) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-07-01) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [388](/filings/0000103379-23-000015.md) | [388](/filings/0000103379-23-000018.md) | [388](/filings/0000103379-24-000003.md) | [388](/filings/0000103379-24-000018.md) | [388](/filings/0000103379-24-000030.md) | [388](/filings/0000103379-25-000007.md) | [389](/filings/0000103379-25-000036.md) | [391](/filings/0000103379-25-000060.md) | [394](/filings/0000103379-26-000011.md) | [390](/filings/0000103379-25-000036.md) | [394](/filings/0000103379-25-000060.md) | [397](/filings/0000103379-26-000011.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 391,769,705 at 2026-04-25, from the cover of the [10-K filed 2026-05-20](/filings/0000103379-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.